Literature DB >> 19460331

Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.

Sylvia Lopes Maia Teixeira1, Francisco Inácio Bastos, Mariana A Hacker, Mariza Gonçalves Morgado.   

Abstract

Host genetic factors play an important role in the HIV epidemic dynamics, and have been considered in studies assessing susceptibility/resistance to HIV-1 infection as well as clinical evolution. Class I and Class II HLA alleles have been associated with the heterogeneity of HIV-1 infection susceptibility, as protective or risk factors for HIV-1 transmission. Moreover, a 32-base pair deletion in the HIV-1 CCR5 gene-coding region confers resistance to HIV-1 infection in homozygous individuals for the deleted allele. In this study, DNA samples from HIV-1 infected and uninfected injecting drug users (IDUs) from Rio de Janeiro were PCR amplified to determine CCR5 genotypes based on the presence of the CCR5Delta32 mutation and typed for the HLA-B locus, in an attempt to assess possible associations between these genetic factors and susceptibility/resistance to HIV-1 infection. The distribution of CCR5 genotypes between the two IDU groups did not differ. The homozygous mutant genotype Delta32/Delta32 was not found in this study. Except for HLA-B*45 (4.0% vs. 3.0%; p=0.04) and for B*51 (12.1% vs. 4.4%; p=0.002), no statistically significant differences were made evident when analyzing the frequencies of each HLA-B allele between Caucasian and non-Caucasian IDUs. The most frequent HLA-B alleles were B*15; B*35; B*44 and B*51. Although some differences in the allele frequencies could be observed between the two IDU groups, none of these was statistically significant. Therefore, no putative association between these genetic markers and susceptibility/resistance to HIV-1 infection could be made evident in the present study. So far, the assessment of genetic markers among the IDU population has been restricted to North American, European, and Asian studies and this report represents a pioneer descriptive study of the distribution of CCR5 genotypes and HLA-B alleles in Rio de Janeiro, Brazil.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460331     DOI: 10.1016/j.meegid.2009.03.007

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

1.  HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.

Authors:  Fernanda H Côrtes; Caroline Pb Passaes; Gonzalo Bello; Sylvia Lm Teixeira; Carla Vorsatz; Dunja Babic; Mark Sharkey; Beatriz Grinsztejn; Valdilea Veloso; Mario Stevenson; Mariza G Morgado
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

2.  Association of the HLA-B*52 allele with non-progression to AIDS in Brazilian HIV-1-infected individuals.

Authors:  S L M Teixeira; N B R de Sá; D P Campos; A B Coelho; M L Guimarães; T C N F Leite; V G Veloso; M G Morgado
Journal:  Genes Immun       Date:  2014-04-10       Impact factor: 2.676

3.  Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil.

Authors:  Josileide Duarte de Farias; Marlene Guimarães Santos; Andonai Krauze de França; Daniel Delani; Mauro Shugiro Tada; Almeida Andrade Casseb; Aguinaldo Luiz Simões; Vera Engracia
Journal:  Genet Mol Biol       Date:  2012-01-06       Impact factor: 1.771

4.  Disparate associations of HLA class I markers with HIV-1 acquisition and control of viremia in an African population.

Authors:  Wei Song; Dongning He; Ilene Brill; Rakhi Malhotra; Joseph Mulenga; Susan Allen; Eric Hunter; Jianming Tang; Richard A Kaslow
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

5.  The CCR5Δ32 polymorphism in Brazilian patients with sickle cell disease.

Authors:  Mariana Pezzute Lopes; Magnun Nueldo Nunes Santos; Eliel Wagner Faber; Marcos André Cavalcanti Bezerra; Betânia Lucena Domingues Hatzlhofer; Dulcinéia Martins Albuquerque; Tânia Regina Zaccariotto; Daniela Maria Ribeiro; Aderson da Silva Araújo; Fernando Ferreira Costa; Maria de Fátima Sonati
Journal:  Dis Markers       Date:  2014-11-11       Impact factor: 3.434

6.  Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study.

Authors:  Baptiste Fouquet; Jade Ghosn; Yann Quertainmont; Dominique Salmon; Christophe Rioux; Claudine Duvivier; Jean-François Delfraissy; Micheline Misrahi
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

Review 7.  CCR5Δ32 in Brazil: Impacts of a European Genetic Variant on a Highly Admixed Population.

Authors:  Bruna Kulmann-Leal; Joel Henrique Ellwanger; José Artur Bogo Chies
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.